BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21237327)

  • 1. [New insights in growth hormone physiology and pathophysiology].
    Kamenicky P; Lombès M; Chanson P
    Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S25-32. PubMed ID: 21237327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.
    Leung KC; Brce J; Doyle N; Lee HJ; Leong GM; Sjögren K; Ho KK
    Endocrinology; 2007 May; 148(5):2417-23. PubMed ID: 17272397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog Treatment.
    Dal J; Høyer KL; Pedersen SB; Magnusson NE; Bjerring P; Frystyk J; Møller N; Jessen N; Jørgensen JO
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3716-3723. PubMed ID: 27466699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and physical performance.
    Birzniece V; Nelson AE; Ho KK
    Trends Endocrinol Metab; 2011 May; 22(5):171-8. PubMed ID: 21420315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2.
    Leung KC; Doyle N; Ballesteros M; Sjogren K; Watts CK; Low TH; Leong GM; Ross RJ; Ho KK
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1016-21. PubMed ID: 12552091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone - hormone replacement for the somatopause?
    Savine R; Sönksen P
    Horm Res; 2000; 53 Suppl 3():37-41. PubMed ID: 10971102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway.
    Flores-Morales A; Fernández L; Rico-Bautista E; Umana A; Negrín C; Zhang JG; Norstedt G
    Mol Endocrinol; 2001 Sep; 15(9):1471-83. PubMed ID: 11518796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone signaling in fibroblasts from newborn boys and prepubertal boys.
    Ocaranza P; Morales F; Matamala Á; Gaete X; Román R; Lammoglia JJ; Cassorla F
    Growth Horm IGF Res; 2016 Apr; 27():18-27. PubMed ID: 26843474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical defects resulting in growth hormone insensitivity.
    Wit JM; de Luca F
    Growth Horm IGF Res; 2016 Jun; 28():57-61. PubMed ID: 26670721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of growth hormone in chronic heart failure. Therapeutic implications.
    Volterrani M; Manelli F; Cicoira M; Lorusso R; Giustina A
    Drugs; 2000 Oct; 60(4):711-9. PubMed ID: 11085197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17β-Estradiol positively modulates growth hormone signaling through the reduction of SOCS2 negative feedback in human osteoblasts.
    Bolamperti S; Mrak E; Moro G; Sirtori P; Fraschini G; Guidobono F; Rubinacci A; Villa I
    Bone; 2013 Jul; 55(1):84-92. PubMed ID: 23567159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of growth hormone-responsive cells in the mouse brain.
    Furigo IC; Metzger M; Teixeira PD; Soares CR; Donato J
    Brain Struct Funct; 2017 Jan; 222(1):341-363. PubMed ID: 27072946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased SULT1E1 activity in HepG2 hepatocytes decreases growth hormone stimulation of STAT5b phosphorylation.
    Li L; He D; Wilborn TW; Falany JL; Falany CN
    Steroids; 2009 Jan; 74(1):20-9. PubMed ID: 18831980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone administration: is it safe and effective for athletic performance.
    Birzniece V; Nelson AE; Ho KK
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):11-23, vii. PubMed ID: 20122446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications.
    Kamenický P; Mazziotti G; Lombès M; Giustina A; Chanson P
    Endocr Rev; 2014 Apr; 35(2):234-81. PubMed ID: 24423979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone signaling in muscle and adipose tissue of obese human subjects: associations with measures of body composition and interaction with resveratrol treatment.
    Clasen BF; Poulsen MM; Escande C; Pedersen SB; Møller N; Chini EN; Jessen N; Jørgensen JO
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2565-73. PubMed ID: 25050904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation.
    Gil-Puig C; Seoane S; Blanco M; Macia M; Garcia-Caballero T; Segura C; Perez-Fernandez R
    Eur J Endocrinol; 2005 Aug; 153(2):335-44. PubMed ID: 16061841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of human growth hormone and its secretagogues.
    Root AW; Root MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):27-52. PubMed ID: 12477295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
    Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
    Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.